LoneStar Heart yesterday presented 1-year data from a follow-up study of its Algisyl hydrogel cardiac implant designed to treat patients with failing heart muscle. The presentation was made at the American Heart Association’s annual meeting in Orlando and published in the European Journal of Heart Failure. Algisyl is a novel inert hydrogel that is designed to be […]